chr1-47137618-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001010969.4(CYP4A22):c.133C>A(p.Leu45Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,614,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001010969.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP4A22 | NM_001010969.4 | c.133C>A | p.Leu45Ile | missense_variant | 1/12 | ENST00000371891.8 | NP_001010969.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP4A22 | ENST00000371891.8 | c.133C>A | p.Leu45Ile | missense_variant | 1/12 | 1 | NM_001010969.4 | ENSP00000360958.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000877 AC: 22AN: 250844Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135548
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461826Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727220
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152368Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.133C>A (p.L45I) alteration is located in exon 1 (coding exon 1) of the CYP4A22 gene. This alteration results from a C to A substitution at nucleotide position 133, causing the leucine (L) at amino acid position 45 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at